Sinmol

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Sinmol

Quick Facts: Sinmol

Property Description
Active ingredient Acetaminophen (Paracetamol)
Form Tablet, Solution, Suppository
Pharmacological class Analgesic and Antipyretic
General use Relief of pain and fever
Origin Synthetic, Aniline derivative

What Type of Medicine is Sinmol and What is its Purpose?

Sinmol is a medicine whose active ingredient is Acetaminophen, an essential compound globally recognized by the synonym Paracetamol. It is firmly classified as a dual-action agent: primarily a non-opioid analgesic (pain reliever) and a reliable antipyretic (fever reducer). The product is clinically recognized for its efficacy in managing common symptoms like tension headaches or fever associated with viral illness. The primary purpose of this medicine is established as providing effective relief from general discomfort and reducing an elevated body temperature.

Composition, Origin, and Available Forms

The active ingredient, Acetaminophen (C8H9NO2), is a synthetic compound derived from the aniline chemical class. It is typically formulated as a single-active-ingredient medicine, though it may be specifically packaged for certain patient groups, such as those requiring liquid formulations. Due to its physicochemical profile, it is available in multiple essential dosage forms, including common oral tablets, liquid suspensions or oral solutions, and suppositories. This versatility allows for its use across diverse patient needs.

How Sinmol Works at a Conceptual Level

Sinmol achieves its efficacy through action within the Central Nervous System (CNS). It is considered distinct from Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) because it primarily influences the perception of pain and the regulation of thermal instability. Its function involves modulating pain signals and acting directly upon the hypothalamus, the brain’s temperature-regulating center, to help lower an elevated body temperature. This focused, centralized mechanism provides the rationale for its classification as an efficient fever reducer and a reliable pain reliever.

Regulatory References

  1. NIH StatPearls Acetaminophen Monograph

What side effects are possible with Sinmol?

Possible Side Effects and Safety Information

The safety profile of Sinmol (Acetaminophen/Paracetamol) is defined by officially documented adverse reactions categorized by frequency and the body system affected. The most serious concern documented in regulatory texts is hepatotoxicity, or liver damage, leading to potential Acute Liver Failure, particularly when the maximum daily dose is exceeded or when co-administered with other acetaminophen-containing products [FDA Prescribing Information on Acetaminophen].

Adverse reactions are classified according to frequency, with several rare but clinically significant events formally documented:

  • Very Rare: Severe cutaneous adverse reactions (SCARs), including Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and Acute Generalized Exanthematous Pustulosis (AGEP), along with anaphylactic and severe hypersensitivity reactions [NIH MedlinePlus Drug Information on Acetaminophen].
  • Not Known: Blood dyscrasias, such as thrombocytopenia (low platelet count) and agranulocytosis (severe drop in white blood cells), and the development of High Anion Gap Metabolic Acidosis (HAGMA).

Less frequently, documented effects involve various organ systems, including gastrointestinal disturbances (nausea, vomiting), nervous system disorders (headache, insomnia), and other skin reactions (rash, pruritus).

Population-Specific Safety Considerations

The medicine is restricted for use in specific populations as outlined in official labeling. It is generally contraindicated in individuals with severe hepatic impairment or severe active liver disease. Individuals with chronic risk factors, such as chronic alcohol use or conditions that lead to severe glutathione depletion (e.g., severe malnutrition), are officially documented as being at a significantly increased risk of hepatotoxicity. Furthermore, caution and potential dose adjustment are specified for patients with severe renal impairment [Health Canada Drug Product Database]. The official safety profile specifies that prolonged, regular daily use in high doses may enhance the effect of oral anticoagulants, increasing the risk of bleeding.

Overdose and Emergency Response

The official regulatory profile for Sinmol (Acetaminophen/Paracetamol) overdose is based on the documented, life-threatening risk of acute liver failure (ALF) and hepatic necrosis. Overdose may initially present with non-specific symptoms such as nausea, vomiting, paleness, and anorexia. Later, severe toxicity progresses to signs of organ failure, including jaundice, confusion, and abdominal pain, often accompanied by abnormal laboratory tests like elevated ALT/AST and INR. Severe overdose can also involve the Renal System, resulting in acute renal failure.

Regulatory authorities mandate that immediate medical attention must be sought, and a Poison Control Center contacted, upon any suspected overdose. Prompt attention is critical even if no symptoms are noticed, as severe injury can be delayed. If a severe, rare reaction like a rash or blistering occurs, use must be stopped immediately.

The treatment structure is defined by the availability of the specific, documented antidote, N-acetylcysteine (NAC), which is indicated to prevent or lessen liver injury. Management requires hospital monitoring, including serial testing of serum acetaminophen concentration to guide treatment. Official labeling also documents increased risk of severe damage for patients with pre-existing liver disease and those who consume alcohol daily.

Therapeutic Uses of Sinmol

What Sinmol Treats: Main Uses and Benefits

Sinmol is generally considered relevant for easing symptoms across therapeutic domains where short-term symptomatic assistance is needed for symptoms related to physical discomfort and systemic imbalance. It is commonly used across conditions characterized by periods of heightened symptoms of mild to moderate pain. This includes aches such as tension headaches, episodic headache manifestations, toothache, muscular aches, and discomfort from menstrual cramps or minor joint conditions like osteoarthritis. The medication is also applied in addressing fever, high temperature, and the generalized body aches often linked to colds or flu.

The medication, by supporting symptomatic relief for both pain and fever, contributes to improved comfort during periods of heightened symptoms and may assist with maintaining functional stability. It is applied in clinical settings that involve acute or unstable symptom patterns, providing support during difficult episodes.

“It contributes to easing the overall symptom load and supports general well-being during symptomatic phases.”

It is commonly used as a symptomatic management option in pregnant individuals and breastfeeding mothers, and it is applied when appropriate for patients who experience difficulties with other forms of symptomatic relief.


Quick Fact: Domains of Relief

Symptom Domain Application Benefit
Pain Mild to moderate aches (headache, toothache, muscle pain) Helps ease overall symptom load
Fever Elevated body temperature Supports general well-being
Context Acute viral illnesses, episodic discomfort May assist with functional stability

Regulatory References

  1. NIH MedlinePlus overview on Acetaminophen

Eligibility and Restrictions for Use

Eligibility and Contraindications

The regulatory profile for Sinmol (Acetaminophen/Paracetamol) defines who can and cannot use the medicine based on absolute prohibitions and necessary restrictions.

Contraindicated Populations: Use is strictly contraindicated in patients with a known hypersensitivity (allergy) to the active substance or its components. Additionally, the medicine must not be used by individuals diagnosed with severe hepatic impairment or severe active liver disease.

Restricted and Conditional Use: Caution is required, and use is restricted, in patients with severe renal impairment (kidney disease), as well as those with non-severe hepatic impairment. Individuals with chronic alcoholism or chronic malnutrition are also subject to restricted use due to increased risk factors.

Age and Life Stage Eligibility: Sinmol is established for use in adults and adolescents. While approved for children, some oral formulations are not recommended for children under 10 years of age. For pregnancy, use is permitted only if clinically needed, and must be restricted to the lowest effective dose for the shortest duration. Use during lactation (breastfeeding) is generally considered suitable.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interaction scope

The regulatory interaction profile for Sinmol (Acetaminophen/Paracetamol) focuses on medicinal products that alter its clearance and those that carry a risk of combined toxic effects. Officially listed substances include Probenecid, Warfarin, Zidovudine, Flucloxacillin, and a category of Liver Enzyme Inducers such as Rifampicin and Phenytoin.

Mechanistic basis and Administration Constraints

Interactions are largely classified as pharmacokinetic, where agents like Probenecid inhibit conjugation, reducing Sinmol's clearance and increasing its systemic exposure. Conversely, Liver Enzyme Inducers are documented to increase the formation of the product's hepatotoxic metabolite. The co-administration of Colestyramine is subject to a specific timing-based separation rule, requiring administration one hour apart to prevent reduced absorption.

Interaction classifications and Context Constraints

Regulatory documents assign a Contraindicated Combination status for Sinmol taken concurrently with any other product containing acetaminophen, due to the documented risk of severe liver damage and overdose. A pharmacodynamic interaction exists with Oral Anticoagulants (Warfarin), where prolonged, regular daily use enhances the anticoagulant effect and necessitates procedural monitoring. The risk of severe hepatotoxic interactions is also officially noted to be greater in populations with chronic alcoholism, hepatic impairment, or malnutrition.

Mechanism of Action

Targeted Enzyme Inhibition in Prostaglandin Pathways

Sinmol acts as a non-selective, competitive inhibitor of the Cyclooxygenase (COX) enzymes (COX-1 and COX-2). This interaction blocks the initial molecular step where arachidonic acid is converted into lipid mediators called prostaglandins (PGs). The suppression of prostaglandin synthesis is the primary biochemical consequence of this interaction.

Dual Central and Peripheral Modulation

This mechanism involves effects across both the central nervous system (CNS) and peripheral tissues, altering signaling patterns regulated by prostaglandins. Inhibition of PG synthesis at sites of tissue damage reduces the sensitization of local pain receptors. The drug also acts within the hypothalamus in the CNS to modulate the body’s elevated temperature set point. This dual action results in the modulation of both peripheral nociceptive signaling and central thermoregulatory pathways.

Downstream Impact on Physiological Control

Sinmol modifies early molecular steps which influence systemic physiological outcomes. By limiting the action of prostaglandins, it leads to a diminished sensitization of nociceptors and a normalization of the hypothalamic temperature set point, which are the physiological bases for analgesic and antipyretic effects. The non-selective nature of the mechanism concurrently influences the constitutive COX-1 pathway, which is associated with temporary changes in baseline physiological regulation, such as gastric mucosal integrity and platelet aggregation.

Dosage and Administration Information

How Sinmol is Used

Sinmol (Acetaminophen/Paracetamol) is administered according to a regulated framework that governs the route, quantity, frequency, and maximum exposure. Prescribing information identifies three primary administration routes: Oral (e.g., tablets, solutions), Rectal (suppositories), and Intravenous (IV) infusion. The choice of route is determined by clinical setting or patient needs.


Official Dosing and Frequency

The standard adult single dose for immediate-release oral forms typically ranges from 325 mg to 1,000 mg. All forms require a minimum time interval of 4 to 6 hours between doses.

Administration Controls

Constraint Official Labeling
Maximum Daily Dose Must not exceed 4,000 mg (4 g) in 24 hours across all routes.
Hepatic Adjustment The daily dose is officially limited to 2,000 mg for patients with specific liver impairment.
Administration Timing Can be taken with or without food.
Duration Constraint Use is constrained to short-term management (e.g., up to 3 days for fever or 10 days for pain).

For intravenous administration, the 1,000 mg dose must be delivered as a slow, 15-minute infusion to ensure procedural adherence to the labeled use. These precise dosage and frequency rules define the boundaries for correct, non-advisory administration.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Sinmol


Evidence for Use in Acute Pain Management (Mild to Moderate)

The primary body of evidence related to Sinmol being studied for pain management comes from short-term Randomized Controlled Trials (RCTs) and Systematic Reviews. These studies were used in research exploring how symptoms change over time, applying mainly to adults experiencing episodic or acute changes in physical discomfort, such as following surgery, or conditions like tension headaches. Researchers studied for how long the reported effects lasted, and they monitored patient-reported outcomes describing perceived discomfort. Some trials also included populations of children being studied for outcomes related to physical discomfort.

Studies conducted during periods of increased symptom activity reported measurements that included changes in pain intensity scores compared to baseline within the initial hours post-dose. Research exploring short-term symptom changes provided insight into how quickly the reported effect was observed and the duration of the observed effect in studies.

Evidence for Use in Reducing Elevated Body Temperature (Antipyresis)

The primary body of evidence related to Sinmol being studied for elevated body temperature comes from an extensive set of short-term Randomized Controlled Trials (RCTs). The research examined adults and children who presented with elevated body temperature due to conditions associated with acute or episodic manifestations.

Findings describe patterns observed in the studies that include measured temperature reduction in subjects with fever within the initial hours after a dose. Studies monitored the rate and extent of this reported effect across different ways the medicine was provided. Comparative evidence with other fever-reducing medications is widely available, and studies described that the magnitude of measured change in temperature was often recorded as similar across the observed groups.

Key Research Limitations and Uncertainties

Research is frequently limited because follow-up durations were limited, typically focusing only on the first few hours or days. Evidence for outcomes related to systemic or functional imbalance over long periods is not fully established. Data for certain groups remain insufficient, particularly regarding outcomes in conditions characterized by functional limitations.

For use during pregnancy, the current non-interventional evidence consists of studies that have documented statistical associations, and the certainty remains low because the findings describe group patterns, not personal outcomes. The influence of confounding factors, such as the underlying maternal condition, remains challenging to account for in the available data.

Key Studies & References

  1. Acetaminophen (Oral Route, Rectal Route, Injectable Route): MedlinePlus Drug Information
  2. Paracetamol for pain relief in children and adolescents: a systematic review

Frequently Asked Questions (FAQ)

Common questions about Sinmol (FAQ)

Q: What is the main purpose of Sinmol, in simple terms?

A: According to official drug information, Sinmol is classified as an analgesic (pain reliever) and antipyretic (fever reducer) agent. In plain terms, its main purpose is to relieve mild to moderate pain and reduce fever.

Q: What is the most common reason doctors prescribe Sinmol?

A: Sinmol is widely used as a first-line agent for treating fever and acute, sudden pain. Regulatory sources indicate it is often prescribed alone for mild-to-moderate discomfort or used alongside other medications for more severe pain.

Q: Does Sinmol make you feel drowsy or tired?

A: Official product labeling does not typically list drowsiness as a common side effect of Sinmol. However, clinical trial data for adult patients has reported insomnia, which means difficulty sleeping.

Q: How quickly can a person expect Sinmol to start working?

A: Official information regarding the oral forms of Sinmol indicates that the drug is absorbed rapidly by the body. Peak concentrations in the blood are usually reached within 30 to 60 minutes after taking a dose.

Q: Is it possible to have an allergic reaction to Sinmol?

A: Yes, the official labeling includes warnings about the risk of serious allergic and hypersensitivity reactions. These reactions can involve swelling of the face, mouth, or throat, difficulty breathing, rash, and a severe reaction called anaphylaxis.

Q: Does Sinmol contain any gluten, lactose, or common allergens?

A: Official product labeling specifies that Sinmol is contraindicated for individuals with a known hypersensitivity to the active substance (Sinmol/Acetaminophen) or to any of the product's excipients (inactive ingredients). Official information notes that a review of the full list of excipients is important to check for specific known allergens.

Q: Can I use Sinmol if I have a history of [common chronic condition, e.g., high blood pressure]?

A: Official labeling advises caution for individuals with certain health conditions that affect how the medicine is processed. These conditions include hepatic impairment (liver problems), active liver disease, chronic alcoholism, chronic malnutrition, and severe renal impairment (kidney problems).

Q: What are the official warnings or precautions listed for Sinmol?

A: The official warnings and precautions listed by the FDA focus on several key risks. These include the potential for Hepatic Injury (liver damage), Serious Skin Reactions (like Stevens-Johnson Syndrome), and Allergy and Hypersensitivity.

Q: Does Sinmol interact with common herbal supplements like St. John's Wort?

A: Official regulatory documents indicate that long-term use of drugs that induce liver enzymes can increase the risk of liver damage. Specific substances mentioned as risk factors include the herbal supplement St. John's Wort, as well as prescription drugs like Carbamazepine or Rifampicin.

Q: Can Sinmol cause problems with my stomach or digestion?

A: Common adverse reactions reported in clinical studies include stomach issues such as nausea and vomiting. Chronic use of high doses of Sinmol has also been associated with abdominal pain and gastrointestinal bleeding.

Q: What should I do if I accidentally take two doses of Sinmol close together?

A: Because of the risk of delayed, serious liver damage, official drug information emphasizes that immediate medical evaluation is necessary in the event of a suspected overdose. This applies even if a person feels well and is not experiencing any immediate symptoms.

Q: Is Sinmol known to be habit-forming or addictive?

A: Sinmol is officially classified as a non-opioid analgesic (pain reliever) and antipyretic (fever reducer) agent. Regulatory and medical sources indicate it is not related to narcotic pain medications.

Q: Does Sinmol affect blood sugar levels?

A: While not a common side effect of typical use, official documentation states that severe poisoning or overdose can lead to abnormalities of glucose metabolism. It can also cause metabolic acidosis, which is an imbalance in the body's acid-base level.

Q: Do I need to be monitored with blood tests while taking Sinmol?

A: Regulatory documents note that the anticoagulant effect of warfarin may be enhanced if taken with prolonged, regular daily use of Sinmol. This combination is noted in regulatory documents as one that necessitates procedural patient monitoring.

Q: What are the signs of a severe but rare side effect of Sinmol?

A: Serious side effects are rare, but the official labeling describes certain signs associated with severe side effects. These include yellowing of the skin or eyes (jaundice), severe upper abdominal pain, and serious skin reactions such as blistering, rash, or significant swelling of the face, throat, or lips.

Q: Can Sinmol impact sleep patterns, either positively or negatively?

A: Clinical trial data for adult patients has reported insomnia, which is a difficulty with sleeping. The official product labeling includes this as an adverse reaction based on the studies.

Q: What is the earliest age someone might be prescribed Sinmol?

A: Dosing recommendations from regulatory sources exist for children as young as 2 years old. However, some combination products containing Sinmol may have further restrictions on use in children.

Q: Does Sinmol have a black box warning from the FDA?

A: Yes. Prescription combination products that contain Sinmol (Acetaminophen) are mandated by the FDA to include a Boxed Warning. This warning highlights the potential for severe liver injury and serious allergic reactions.

Q: What are the key points to discuss with a healthcare provider before starting Sinmol?

A: Official safety communications recommend discussing several key points with a healthcare provider. These include any history of liver disease, the total maximum daily dose being taken from all sources, regular alcohol consumption (three or more drinks per day), and any known history of severe skin reactions or hypersensitivity to the product.

How should Sinmol be stored and disposed of?

How to Store and Dispose of Sinmol

Sinmol (Acetaminophen) must be stored at controlled room temperature, specifically between 20 C and 25 C (68 F and 77 F). The product must be kept in the original container, which should remain tightly closed when not in use.

Storage Constraints

Condition Requirement
Temperature Do not freeze or store in hot, damp places.
Protection Keep protected from moisture and light.
Safety Keep out of the sight and reach of children.

Disposal Requirements

Unused or expired Sinmol should be disposed of using a drug take-back program when available. If a take-back program is not accessible, the unused medicine must be mixed with an undesirable substance (such as dirt or coffee grounds) and placed into a sealed container for household trash. The medicine must not be flushed down a toilet or poured into a sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Sinmol found in:

A-Z Index: